160 related articles for article (PubMed ID: 23535315)
21. Retrospective analysis of treatment outcomes for extranodal NK/T-cell lymphoma (ENKL), nasal type, stage I-IIE: single institute experience of combined modality treatment for early localized nasal extranodal NK/T-cell lymphoma (ENKL).
Lee J; Cho SG; Chung SM; Ryu MR; Kim SH; Jang HS; Choi BO
Ann Hematol; 2013 Mar; 92(3):333-43. PubMed ID: 23180438
[TBL] [Abstract][Full Text] [Related]
22. [Value of PET/CT in the prognosis of extranodal NK/T cell lymphoma].
Dong GH; Li Y; Wan HF; He CY; Yang L; Wang JW; Gong LP; Zhao YH; Gao ZF; Liu HG
Zhonghua Yi Xue Za Zhi; 2018 Apr; 98(16):1256-1260. PubMed ID: 29747315
[No Abstract] [Full Text] [Related]
23. Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in the treatment of stage IE/IIE extranodal natural killer/T cell lymphoma, nasal type: 13-year follow-up in 135 patients.
Wang L; Xia ZJ; Huang HQ; Lu Y; Zhang YJ
Int J Hematol; 2012 Nov; 96(5):617-23. PubMed ID: 22983648
[TBL] [Abstract][Full Text] [Related]
24. Patterns of Primary Tumor Invasion and Regional Lymph Node Spread Based on Magnetic Resonance Imaging in Early-Stage Nasal NK/T-cell Lymphoma: Implications for Clinical Target Volume Definition and Prognostic Significance.
Wu RY; Liu K; Wang WH; Jin J; Song YW; Wang SL; Liu YP; Ren H; Fang H; Liu QF; Yang Y; Chen B; Qi SN; Lu NN; Tang Y; Tang Y; Li N; Ouyang H; Li YX
Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):50-59. PubMed ID: 27816363
[TBL] [Abstract][Full Text] [Related]
25. The prognostic nutritional index predicts survival for patients with extranodal natural killer/T cell lymphoma, nasal type.
Chen KL; Liu YH; Li WY; Chen J; Gu YK; Geng QR; Jiang WQ; Huang HQ; Lin TY; Xia ZJ; Cai QQ
Ann Hematol; 2015 Aug; 94(8):1389-400. PubMed ID: 25869028
[TBL] [Abstract][Full Text] [Related]
26. [Extranodal NK/T-cell lymphoma, nasal type: a clinical analysis].
Chen F; Shen CX; Wang HG; Li GX; Wang XQ; Wen Z
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Mar; 31(5):327-333. PubMed ID: 29871255
[No Abstract] [Full Text] [Related]
27. Ki-67 expression is predictive of prognosis in patients with stage I/II extranodal NK/T-cell lymphoma, nasal type.
Kim SJ; Kim BS; Choi CW; Choi J; Kim I; Lee YH; Kim JS
Ann Oncol; 2007 Aug; 18(8):1382-7. PubMed ID: 17693651
[TBL] [Abstract][Full Text] [Related]
28. Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma.
Li YX; Yao B; Jin J; Wang WH; Liu YP; Song YW; Wang SL; Liu XF; Zhou LQ; He XH; Lu N; Yu ZH
J Clin Oncol; 2006 Jan; 24(1):181-9. PubMed ID: 16382127
[TBL] [Abstract][Full Text] [Related]
29. Promising clinical outcomes of sequential and "Sandwich" chemotherapy and extended involved-field intensity-modulated radiotherapy in patients with stage I
Wang HY; Niu SQ; Yang YY; Li YY; Chen HB; Zhang YJ
Cancer Med; 2018 Dec; 7(12):5863-5869. PubMed ID: 30484966
[TBL] [Abstract][Full Text] [Related]
30. Novel and simple prognostic index for nasal natural killer/T-cell lymphoma.
Hanakawa H; Orita Y; Sato Y; Takao S; Marunaka H; Morishita T; Yamashita Y; Hori Y; Domae S; Inokuchi I; Akagi S; Kondo E; Iwaki N; Motomiya K; Okumura H; Yoshino T; Nishizaki K
Head Neck; 2014 Apr; 36(4):551-6. PubMed ID: 23780926
[TBL] [Abstract][Full Text] [Related]
31. Concurrent Etoposide, Steroid, High-dose Ara-C and Platinum chemotherapy with radiation therapy in localised extranodal natural killer (NK)/T-cell lymphoma, nasal type.
Michot JM; Mazeron R; Danu A; Lazarovici J; Ghez D; Antosikova A; Willekens C; Chamseddine AN; Minard V; Dartigues P; Bosq J; Carde P; Koscielny S; De Botton S; Ferme C; Girinsky T; Ribrag V
Eur J Cancer; 2015 Nov; 51(16):2386-95. PubMed ID: 26254810
[TBL] [Abstract][Full Text] [Related]
32. Nasopharyngeal/nasal type NK/T lymphoma: analysis of 23 cases and current review of the literature.
Youssef YB; Bougmiza I; Bouabid Z; Achour B; Regaieg H; Sriha B; Belkadhi M; Omri HE; Khelif A
Kulak Burun Bogaz Ihtis Derg; 2012; 22(5):275-83. PubMed ID: 22991988
[TBL] [Abstract][Full Text] [Related]
33. High numbers of CD68+ tumor-associated macrophages correlate with poor prognosis in extranodal NK/T-cell lymphoma, nasal type.
Wang H; Li P; Wang L; Xia Z; Huang H; Lu Y; Li Z
Ann Hematol; 2015 Sep; 94(9):1535-44. PubMed ID: 25990795
[TBL] [Abstract][Full Text] [Related]
34. Extranodal NK/T-cell lymphoma with cutaneous involvement: 'nasal' vs. 'nasal-type' subgroups--a retrospective study of 18 patients.
Choi YL; Park JH; Namkung JH; Lee JH; Yang JM; Lee ES; Lee DY; Jang KT; Ko YH
Br J Dermatol; 2009 Feb; 160(2):333-7. PubMed ID: 19014396
[TBL] [Abstract][Full Text] [Related]
35. A comparison of treatment modalities for nasal extranodal natural killer/T-cell lymphoma in early stages: The efficacy of CHOP regimen based concurrent chemoradiotherapy.
Cao J; Lan S; Shen L; Si H; Zhang N; Li H; Guo R
Oncotarget; 2017 Mar; 8(12):20362-20370. PubMed ID: 27901491
[TBL] [Abstract][Full Text] [Related]
36. CD30 expression is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type.
Li P; Jiang L; Zhang X; Liu J; Wang H
BMC Cancer; 2014 Nov; 14():890. PubMed ID: 25429803
[TBL] [Abstract][Full Text] [Related]
37. Extranodal natural killer/T-Cell lymphoma: A population-based comparison of sinonasal and extranasal disease.
Vazquez A; Khan MN; Blake DM; Sanghvi S; Baredes S; Eloy JA
Laryngoscope; 2014 Apr; 124(4):888-95. PubMed ID: 24114591
[TBL] [Abstract][Full Text] [Related]
38. Natural Killer/T Cell Lymphoma, Nasal Type: A Retrospective Clinical Analysis in North-Western China.
Liang R; Wang Z; Bai QX; Gao GX; Yang L; Zhang T; Gu HT; Dong BX; Shu MM; Hao CX; Zhang N; Chen XQ
Oncol Res Treat; 2016; 39(1-2):45-52. PubMed ID: 26891121
[TBL] [Abstract][Full Text] [Related]
39. Both c-Myc and Ki-67 expression are predictive markers in patients with extranodal NK/T-cell lymphoma, nasal type: a retrospective study in China.
Huang X; Sun Q; Fu H; Zhou X; Guan X; Wang J
Pathol Res Pract; 2014 Jun; 210(6):351-6. PubMed ID: 24642368
[TBL] [Abstract][Full Text] [Related]
40. Immunophenotypic and clinical differences between the nasal and extranasal subtypes of upper aerodigestive tract natural killer/T-cell lymphoma.
Liu QF; Wang WH; Wang SL; Liu YP; Huang WT; Lu N; Zhou LQ; Ouyang H; Jin J; Li YX
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):806-13. PubMed ID: 24495590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]